Medpace Bioanalytical Laboratories (MBL) is continuously working with our sponsors to expand our commercially available assay lists, as well as our proprietary assay list.
All of our assays are developed in a Good Laboratory Practice (GLP) environment, following either MBL Standard Operating Procedures (SOPs) or our sponsor’s SOPs depending on the requirements for the assay. All of our validated assays meet the FDA guidance for bioanalytical method validation. When developing a new assay, we build upon our senior management’s experience of over 20 years of bioanalytical method development. This allows us to develop and validate many assays in a shorter time frame than our competitors.
Medpace bioanalytical laboratory scientists are well-known, industry leaders. Our scientific experts are often called upon for consultation and have developed scientific posters for presentation purposes. All Medpace bioanalytical posters can be accessed in the resource center or via the links below.
Simultaneous Determination of Dehydroepiandrosterone (DHEA) and 17-Hydroxyprogesterone (17-OHP) in Human Plasma usingUPLC-MS/MS